|
Etiology
No evidence is cited.
Epidemiology
No evidence is cited.
Diagnosis
Clinical Diagnosis
Five clinical findings:
-
Maxillary toothache
-
Poor response to decongestants
-
A history of colored nasal discharge
-
Purulent nasal secretion
-
Transillumination result (useful only if negative)
are the best predictors of acute bacterial
sinusitis (level I evidence). When <2 of these findings was present
sinusitis could be ruled out; however, when >3 are present, the likelihood
of sinusitis is very high. When 2 or 3 findings are present a Waters
view may be useful (level III evidence).
-
Caveats
-
Age group studied: Unknown
-
Type/size: Hierarchical evaluation of the
strength of evidence in the medical literature and consensus of experts.
Emphasis was placed on randomized, placebo-controlled clinical trials (level
I evidence) and well-designed controlled trials without randomization (level
II evidence) when available. Opinions of respected authorities based on
clinical experience, descriptive studies and reports of expert committees
(level III evidence) were assigned a lower weight.
-
Population characteristics: Unknown
-
Outcome measures: Unknown
-
Citations
The following signs and symptoms increase
the likelihood of bacterial sinusitis:
-
"Double-sickening" (an upper respiratory infection
that initially improves then worsens)
-
Purulent secretions by history
-
Purulent secretions in the nasal cavity on
examination
-
Lack of response to decongestants and antihistamines
-
Unilateral maxillary pain
Facial pain on percussion or palpation, sedimentation
rate and white blood count have little diagnostic value.
-
Caveats
-
Age group studied: 15+
-
Type/size: Population study of 251 patients
-
Population characteristics: Primary care patients
-
Outcome measure: Test characteristics of signs,
symptoms, and lab tests for acute sinusitis
-
Citation
Laboratory/X-ray Diagnosis
Regarding the following five clinical
findings:
-
Maxillary toothache
-
Poor response to decongestants
-
A history of colored nasal discharge
-
Purulent nasal secretion
-
Transillumination result (useful only if negative)
Radiography is not warranted when <2
or >3 of these findings are present. When 4 or more are present, the likelihood
of sinusitis is very high. A Waters view is useful when the diagnosis is
in doubt (level III evidence). CT scans are not cost-effective and should
not be used routinely to diagnose acute sinusitis (level II evidence).
-
Caveats
-
Age group studied: Unknown
-
Type/size: Hierarchical evaluation of the
strength of evidence in the medical literature and consensus of experts.
Emphasis was placed on randomized, placebo-controlled clinical trials (level
I evidence) and well-designed controlled trials without randomization (level
II evidence) when available. Opinions of respected authorities based on
clinical experience, descriptive studies and reports of expert committees
(level III evidence) were assigned a lower weight.
-
Population characteristics: Unknown
-
Outcome measure: Unknown
-
Citations
Treatment
Antibiotics
No specific antibiotic is likely to be
helpful in most cases of acute maxillary sinusitis. It may be more appropriate
to prescribe antibiotics only for patients who are sicker, or at higher
risk for complications. When antibiotics are used, clinicians should choose
the cheapest and most convenient agent available. Optimal duration of therapy
remains controversial.
-
Caveats
-
Age group studied: Adults >13y
-
Type/size: Meta-analysis (16 studies = 3310
patients)
-
Population characteristics: Otherwise healthy
adults
-
Outcome measure: Clinical cure, clinical success,
and adverse events
-
Citations
In the event that antibiotics are used, first-line
therapy should be a 10-day course of amoxicillin or trimethoprim
sulfamethoxazole (level I evidence) and a decongestant (level
III evidence). Patients not responding to first-line therapy should be
switched to a second-line agent (any agent with an approved indication
for acute bacterial sinusitis other than amoxicillin and TMPSMX).
As well, patients with recurrent episodes of acute sinusitis who have been
assessed and found not to have anatomic anomalies may also benefit from
second-line therapy (level III evidence).
-
Caveats
-
Age group studied: Unknown
-
Type/size: Hierarchical evaluation of the
strength of evidence in the medical literature and consensus of experts.
Emphasis was placed on randomized, placebo-controlled clinical trials (level
I evidence) and well-designed controlled trials without randomization (level
II evidence) when available. Opinions of respected authorities based on
clinical experience, descriptive studies and reports of expert committees
(level III evidence) were assigned a lower weight.
-
Population characteristics: Unknown
-
Outcome measure: Unknown
-
Citations
In the event that antibiotics are used, three
days of trimethoprim/sulfasoxazole (TMP/SMX) is as effective as
10 days of TMP/SMX in the treatment of acute maxillary sinusitis (77% and
76% cured or much improved at 14 days).
-
Caveats
-
Age group studied: Adult males
-
Type/size: RCT of 80 patients
-
Population characteristics: VA outpatients
and staff
-
Outcome measure: Number of days to cure or
much improvement, relapse rate and x-ray improvement
-
All patients received oxymatazolone nasal
spray x 3 days
-
But then, if antibiotics are ineffective in
the treatment of sinusitis, there would not be any difference among
regimens (!)
-
Citations
Cefprozil, cefpodoxime proxetil, loracarbef,
cefixime, and ceftibuten were compared to conventional antibiotic
therapies (usually amoxicillin/clavulanate, cefaclor or cephalexin)
for community acquired infections. Infections included acute otitis media,
pharyngitis, sinusitis, bronchitis, pneumonia, urinary tract infection
and skin and skin-structure infections. The newer agents appear to be as
clinically effective as conventional therapies (but not more effective)
for the treatment of common community-acquired infections. They may also
have the potential to improve compliance due to their once/twice daily
mode of
administration.
-
Caveats
-
Age group studied: Unknown
-
Type/size: Analytical review of studies: acute
otitis media: 19 studies, pharyngitis: 13 studies, sinusitis: 4 studies,
bronchitis: 10 studies, pneumonia: 7 studies, urinary tract infection:
11 studies, skin and skin-structure infections: 4 studies. Most studies
consisted of 30-50 patients in each arm
-
Population: Unknown
-
Outcome measure: Clinical response to therapy
-
For some of these infections other studies
show that there is no evidence that any antibiotic therapy is beneficial
-
Citations
Amoxicillin and trimethoprim/sulfasoxazole
are essentially as effective as more expensive antibiotics for the initial
treatment of uncomplicated acute sinusitis.
-
Caveats
-
Age group studied: Unknown
-
Type/size: Meta-analysis of 27 RCTs (2717
patients)
-
Population characteristics: Outpatients with
acute sinusitis or acute exacerbations of chronic sinusitis
-
Outcome measures: Clinical failures and cures
-
But is this finding because NO antibiotic
is particularly effective for the treatment of sinusitis?
-
Citations
Receiving a prescription for an antibiotic
for a URI was not associated with increased patient satisfaction. Better
to spend time explaining the nature of a particular illness and the physician's
choice of treatment.
-
Caveats
-
Age group: Adults
-
Type/size: RCT of 113
-
Outcome measure: Patient satisfaction
-
Diagnostic criteria unclear
-
Citations
Other Therapies
-
Decongestants, along with antimicrobial
therapy, are useful in treating acute sinusitis (level III evidence).
-
Antihistamines are contraindicated
in the management of acute sinusitis (level III evidence).
-
Glucocorticosteroids have not been
shown to be of any notable benefit in treating acute sinusitis (level III
evidence).
-
Irrigation of the nasal cavity may
provide symptomatic relief (level III evidence).
-
Caveats
-
Age group studied: Unknown
-
Type/size: Hierarchical evaluation of the
strength of evidence in the medical literature and consensus of experts.
Emphasis was placed on randomized, placebo-controlled clinical trials (level
I evidence) and well-designed controlled trials without randomization (level
II evidence) when available. Opinions of respected authorities based on
clinical experience, descriptive studies and reports of expert committees
(level III evidence) were assigned a lower weight.
-
Population characteristics: Unknown
-
Outcome measure: Unknown
-
Citations
Monitoring
No evidence is cited.
Prognosis
No evidence is cited.
Prevention
No evidence is cited.
Patient Education
The following patient education materials
are consistent with the available evidence.
Rev. 8/28/99
|